NO20020664L - Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner - Google Patents

Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner

Info

Publication number
NO20020664L
NO20020664L NO20020664A NO20020664A NO20020664L NO 20020664 L NO20020664 L NO 20020664L NO 20020664 A NO20020664 A NO 20020664A NO 20020664 A NO20020664 A NO 20020664A NO 20020664 L NO20020664 L NO 20020664L
Authority
NO
Norway
Prior art keywords
avermectins
determines
ratio
streptomyces avermitilis
avermitilis gene
Prior art date
Application number
NO20020664A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020664D0 (no
Inventor
Yan Chen
Claes Gustafsson
Anke Krebber
Jeremy Stephen Minshull
Sun Ai Raillard
Kim Jonelle Stutzman-Engwall
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO20020664D0 publication Critical patent/NO20020664D0/no
Publication of NO20020664L publication Critical patent/NO20020664L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52Genes encoding for enzymes or proenzymes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623Avermectin; Milbemycin; Ivermectin; C-076

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20020664A 1999-08-12 2002-02-11 Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner NO20020664L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14864599P 1999-08-12 1999-08-12
PCT/IB2000/001017 WO2001012821A1 (en) 1999-08-12 2000-07-24 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins

Publications (2)

Publication Number Publication Date
NO20020664D0 NO20020664D0 (no) 2002-02-11
NO20020664L true NO20020664L (no) 2002-02-11

Family

ID=22526696

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020664A NO20020664L (no) 1999-08-12 2002-02-11 Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner

Country Status (39)

Country Link
US (3) US6632673B1 (cs)
EP (1) EP1200606B1 (cs)
JP (1) JP3884651B2 (cs)
KR (1) KR100489856B1 (cs)
CN (1) CN1186446C (cs)
AP (1) AP2002002418A0 (cs)
AR (1) AR022646A1 (cs)
AT (1) ATE341632T1 (cs)
AU (1) AU778837B2 (cs)
BG (1) BG65902B1 (cs)
BR (1) BRPI0013119B8 (cs)
CA (1) CA2380872C (cs)
CO (1) CO5290295A1 (cs)
CY (1) CY1105778T1 (cs)
CZ (1) CZ304402B6 (cs)
DE (1) DE60031126T2 (cs)
DK (1) DK1200606T3 (cs)
EA (1) EA200200056A1 (cs)
ES (1) ES2272299T3 (cs)
GT (1) GT200000136A (cs)
HK (1) HK1046710B (cs)
HR (1) HRP20020130A2 (cs)
HU (1) HU230600B1 (cs)
IL (2) IL147563A0 (cs)
IS (1) IS6250A (cs)
MA (1) MA26813A1 (cs)
MX (1) MXPA02001513A (cs)
NO (1) NO20020664L (cs)
NZ (1) NZ516517A (cs)
OA (1) OA11998A (cs)
PA (1) PA8499501A1 (cs)
PE (1) PE20010690A1 (cs)
PL (1) PL203818B1 (cs)
PT (1) PT1200606E (cs)
SK (1) SK288086B6 (cs)
TN (1) TNSN00171A1 (cs)
UY (1) UY26286A1 (cs)
WO (1) WO2001012821A1 (cs)
ZA (1) ZA200201072B (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL203818B1 (pl) * 1999-08-12 2009-11-30 Pfizer Prod Inc Cząsteczka polinukleotydowa, zrekombinowany wektor, komórka gospodarz Streptomyces, sposób wytwarzania nowego szczepu S. avermitilis, komórka Streptomyces avermitilis, sposób wytwarzania awermektyn i kompozycja awermektyn cykloheksylo-B2:cykloheksylo-B1
PT2050815E (pt) 2002-02-12 2012-01-02 Pfizer Prod Inc Gene de «streptomyces avermitilis que regula a proporção de avermectinas b2:b1»
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US9493744B2 (en) * 2012-06-20 2016-11-15 Genentech, Inc. Methods for viral inactivation and other adventitious agents
KR102657859B1 (ko) 2021-04-07 2024-04-16 윤재식 일체형 내화 소켓

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN167980B (cs) * 1987-01-23 1991-01-19 Pfizer
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
ATE89604T1 (de) 1987-10-23 1993-06-15 Pfizer Verfahren zur herstellung von aglykonen von avermectin und sie enthaltende kulturen.
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
ES2079436T3 (es) 1989-03-31 1996-01-16 Merck & Co Inc Clonacion de genes de streptomyces avermitilis para biosintesis de avermectinas y procedimientos para su uso.
JP2807348B2 (ja) 1993-07-30 1998-10-08 ファイザー・インコーポレーテッド ストレプトミセス・アベルミティリスからの分岐状鎖α−ケト酸デヒドロゲナーゼ複合体をコードする遺伝子
FI942725L (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
WO1998013487A1 (en) 1996-09-27 1998-04-02 Maxygen, Inc. Methods for optimization of gene therapy by recursive sequence shuffling and selection
KR100568008B1 (ko) 1997-01-17 2006-04-07 맥시겐, 인크. 반복적 서열 재조합에 의한 전세포 및 유기체의 개량 방법
AU1449499A (en) 1997-10-31 1999-05-24 Maxygen, Incorporated Modification of virus tropism and host range by viral genome shuffling
US6248579B1 (en) * 1998-02-13 2001-06-19 Pfizer Inc Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins
KR20040099389A (ko) * 1998-02-13 2004-11-26 화이자 프로덕츠 인코포레이티드 스트렙토마이세스 하이그로스코피쿠스 유전자
PL203818B1 (pl) * 1999-08-12 2009-11-30 Pfizer Prod Inc Cząsteczka polinukleotydowa, zrekombinowany wektor, komórka gospodarz Streptomyces, sposób wytwarzania nowego szczepu S. avermitilis, komórka Streptomyces avermitilis, sposób wytwarzania awermektyn i kompozycja awermektyn cykloheksylo-B2:cykloheksylo-B1

Also Published As

Publication number Publication date
ES2272299T3 (es) 2007-05-01
TNSN00171A1 (fr) 2005-11-10
WO2001012821A1 (en) 2001-02-22
CA2380872A1 (en) 2001-02-22
HK1046710A1 (en) 2003-01-24
BG106479A (bg) 2002-10-31
HUP0202487A2 (en) 2002-10-28
HRP20020130A2 (en) 2003-06-30
HUP0202487A3 (en) 2004-07-28
PL353874A1 (en) 2003-12-01
EP1200606B1 (en) 2006-10-04
PT1200606E (pt) 2006-12-29
US20040009560A1 (en) 2004-01-15
PL203818B1 (pl) 2009-11-30
HK1046710B (zh) 2005-05-13
UY26286A1 (es) 2001-03-16
GT200000136A (es) 2002-02-01
JP2003507017A (ja) 2003-02-25
ATE341632T1 (de) 2006-10-15
IL147563A (en) 2009-06-15
PA8499501A1 (es) 2001-12-14
OA11998A (en) 2006-04-18
CN1373809A (zh) 2002-10-09
SK288086B6 (sk) 2013-06-03
NO20020664D0 (no) 2002-02-11
AU5838600A (en) 2001-03-13
CO5290295A1 (es) 2003-06-27
MA26813A1 (fr) 2004-12-20
DE60031126T2 (de) 2007-02-08
DK1200606T3 (da) 2007-01-08
BG65902B1 (bg) 2010-04-30
CZ2002296A3 (cs) 2002-08-14
CY1105778T1 (el) 2011-02-02
PE20010690A1 (es) 2001-07-06
CN1186446C (zh) 2005-01-26
CA2380872C (en) 2007-11-27
MXPA02001513A (es) 2002-07-02
AU778837B2 (en) 2004-12-23
BR0013119A (pt) 2002-04-23
AP2002002418A0 (en) 2002-03-31
IS6250A (is) 2002-01-25
HU230600B1 (hu) 2017-02-28
KR100489856B1 (ko) 2005-05-17
NZ516517A (en) 2003-10-31
US20030232415A1 (en) 2003-12-18
SK1392002A3 (en) 2002-12-03
EP1200606A1 (en) 2002-05-02
IL147563A0 (en) 2002-08-14
BRPI0013119B8 (pt) 2021-05-25
DE60031126D1 (de) 2006-11-16
AR022646A1 (es) 2002-09-04
EA200200056A1 (ru) 2002-06-27
ZA200201072B (en) 2003-04-30
KR20020029379A (ko) 2002-04-18
JP3884651B2 (ja) 2007-02-21
US6632673B1 (en) 2003-10-14
CZ304402B6 (cs) 2014-04-16
BR0013119B1 (pt) 2014-02-25
US7858340B2 (en) 2010-12-28

Similar Documents

Publication Publication Date Title
AU2002224436A1 (en) Partition system with elevated raceway
MXPA03001775A (es) Derivados de nucleosidos.
AU5515901A (en) Gamma-phosphoester nucleoside triphosphates
AU2002363246A1 (en) Game with multiple chambers
ZA200403684B (en) Macrolides.
AU2001278694A1 (en) Avermectin derivatives
AU2002224409A1 (en) Partition system with worktools
AU2002330717A1 (en) Monosaccharide derivatives
AU2001241910A1 (en) Distributed least choice first arbiter
NO20020665D0 (no) Streptomyces Avermitilis gen som bestemmer forholdet til B2:B1 avermectiner
ZA995872B (en) Streptomyces avermitilis regulatory genes for increased avermectin production.
NO20020664D0 (no) Streptomyces Avermitilis gen som bestemmer forholdet B2:B1 avermectiner
AU2001275898A1 (en) Avermectin pesticide with an organosilicone surfactant
ZA991138B (en) Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins.
AU5789001A (en) Macrolide antiinfective agents
AU2002230386A1 (en) Sixteen-membered macrolide compounds
ZA200405345B (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
AU2002317415A1 (en) Azalide antibiotic compositions
DK1200605T3 (da) Streptomyces avermitilis gen, der dirigerer forholdet imellem B2:B1 avermectiner
AU2003285599A1 (en) Novel semisynthetic macrolide antibiotics of the azalide series
AU2690500A (en) Avermectin aglycon synthase genes
AU2003243789A1 (en) 11-c-substituted ketolides
AU2002346601A1 (en) Novel 11-o-substituted ketolide derivatives
AU2002249774A1 (en) Interconnect
HK1054840A (en) Interconnect

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application